Noninvasive monitoring of glutathione turnover in perfused MCF-7 cells

Free Radical Biology and Medicine

Volumn 37, Issue 7, 2004, Pages 961-968

  Gamcsik, Michael P ^a,b   Bierbryer, Ross G ^a   Millis, Kevin K ^b,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CAMBRIDGE ISOTOPE LABORATORIES INC   (United States)

Author keywords

Cancer; Drug resistance; Free radicals; Glutathione; Isotope tracers; Magnetic resonance; Metabolism

Indexed keywords

4 HYDROPEROXYCYCLOPHOSPHAMIDE; CARBON 13; DOXORUBICIN; GLUTATHIONE;

ARTICLE; CALCULATION; CANCER CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; LABELING INDEX; MONITORING; MONOLAYER CULTURE; NONLINEAR SYSTEM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBSERVATION; PERFUSION; PRIORITY JOURNAL; PULSE RATE; WILD TYPE;

BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; GLUTATHIONE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; PERFUSION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 4444332858     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2004.06.024     Document Type: Article

References (27)

1. G.D. Kruh Introduction to resistance to anticancer agents Oncogene 22 2003 7262 7264
2. J.D. Hayes, and L.I. McLellan Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress Free Radic. Res. 31 1999 273 300
3. K.D. Tew Glutathione-associated enzymes in anticancer drug resistance Cancer Res. 54 1994 4313 4320
4. X. Cheng, J. Kigawa, Y. Minigawa, Y. Kanamori, H. Itamochi, M. Okada, and N. Terakawa Glutathione S-transferase-Ï€ expression and glutathione concentration in ovarian carcinoma before and after chemotherapy Cancer 79 1997 521 527
5. S.C. Barranco, R.R. Perry, M.E. Durm, M. Quraishi, A.L. Werner, S.G. Gregorcyk, and P. Kolm Relationship between colorectal cancer glutathione levels and patient survival: early results Dis. Colon Rectum 43 2000 1133 1140
6. F. Joncourt, K. Buser, H. Altermatt, M. Bacchi, A. Oberli, and T. Cerny Multiple drug resistance parameter expression in ovarian cancer Gynecol. Oncol. 70 1998 176 182
7. S.C. Barranco, R.R. Perry, M.E. Durm, A.L. Werner, S.G. Gregorcyk, W.E. Bolton, P. Kolm, and C.M. Townsend Jr. Intratumor variability in prognostic indicators may be the cause of conflicting estimates of patient survival and response to therapy Cancer Res. 54 1994 5351 5356
8. M.P. Gamcsik, G.R. Dubay, and B.R. Cox Increased rate of glutathione synthesis from cystine in drug-resistant MCF-7 cells Biochem. Pharmacol. 63 2002 843 851
9. M.P. Gamcsik, J.R. Forder, K.K. Millis, and K.A. McGovern A versatile oxygenator and perfusion system for magnetic resonance studies of tissues and organs Biotechnol. Bioeng. 49 1996 348 354
10. C.R. Fairchild, S.P. Ivy, C.-S. Kao-Shan, J. Whang-Peng, N. Rosen, M.A. Israel, P.W. Melera, K.H. Cowan, and M.E. Goldsmith Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells Cancer Res. 47 1987 5141 5148
11. G. Batist, A. Tulpule, B.K. Sinha, A.G. Katki, C.E. Myers, and K.H. Cowan Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells J. Biol. Chem. 261 1986 15544 15549
12. E. Frei III, B.A. Teicher, S.A. Holden, K.N.S. Cathcart, and Y. Wang Preclinical studies and clinical correlation of the effect of alkylating dose Cancer Res. 48 1988 6417 6423
13. B.A. Teicher, S.A. Holden, J.P. Eder, T.W. Brann, S.M. Jones, and E.M. Frei III Influence of schedule on alkylating agent cytotoxicity in vitro and in vivo Cancer Res. 49 1989 5994 5998
14. P.K. Smith, R.I. Krohn, G.T. Hermanson, A.K. Mallia, F.H. Gartner, M.D. Provenzano, E.K. Fujimoto, N.M. Goeke, B.J. Olson, and D.C. Klenk Measurement of protein using bicinchoninic acid Anal. Biochem. 150 1985 76 85
15. A.S. Bender, W. Reichelt, and M.D. Norenberg Characterization of cystine uptake in cultured astrocytes Neurochem. Int. 37 2000 269 276
16. O.W. Griffith, and R.T. Mulcahy The enzymes of glutathione synthesis: γ-glutamylcysteine synthetase Adv. Enzymol. Relat. Areas Mol. Biol. 73 1999 209 267
17. C.G. Taylor, L.E. Nagy, and T.M. Bray Nutritional and hormonal regulation of glutathione biosynthesis Curr. Top. Cell. Regul. 34 1996 189 208
18. K. Buser, F. Joncourt, H.J. Altermatt, M. Bacchi, A. Oberli, and T. Cerny Breast cancer: pretreatment drug resistance parameters (GSH-system, ATase, P-glycoprotein) in tumor tissue and their correlation with clinical and prognostic characteristics Ann. Oncol. 8 1997 335 341
19. J.A. Willis, and T. Schleich C-13 NMR spectroscopic measurement of glutathione synthesis and antioxidant metabolism in the intact ocular lens Biochem. Biophys. Res. Commun. 186 1992 931 935
20. 13C-NMR spectroscopic studies of 2-mercaptoethanol-stimulated glutathione synthesis in the intact ocular lens Biochim. Biophys. Acta Mol. Cell. Res. 1265 1995 1 7
21. J.A. Willis, and T. Schleich Oxidative-stress induced protein glutathione mixed-disulfide formation in the ocular lens Biochim. Biophys. Acta 1313 1996 20 28
22. 13C NMR Magn. Reson. Med. 48 2002 430 439
23. A. Meister Glutathione metabolism Methods Enzymol. 251 1995 3 7
24. R.R. Wolfe Radioactive and stable isotope tracers in biomedicine: principles and practice of kinetic analysis 1992 Wileyâ€"Liss New York
25. K.K. Millis, S.A. Lesko, and M.P. Gamcsik Formation, intracellular distribution and efflux of glutathioneâ€"bimane conjugates in drug-sensitive and -resistant MCF-7 cells Cancer Chemother. Pharmacol. 40 1997 101 111
26. F.Y.F. Lee, D.W. Siemann, M.J. Allalunis-Turner, and P.C. Keng Glutathione contents in human and rodent tumor cells in various phases of the cell cycle Cancer Res. 1988 1988 3661 3665
27. F.Y.F. Lee, D.W. Siemann, and R.M. Sutherland Changes in cellular glutathione content during adriamycin treatment in human ovarian cancer: a possible indicator of chemosensitivity Br. J. Cancer 60 1989 291 298